BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Diagnosis
215 results:

  • 1. [Expression of immune checkpoints PD-L1, ctla4, LAG3 in the microenvironment of colon adenocarcinoma depending on MMR status].
    Naumov SS; Krakhmal NV; Tashireva LA; Vtorushin SV
    Arkh Patol; 2024; 86(2):6-13. PubMed ID: 38591901
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Exploring the clinical significance of IL-38 correlation with PD-1, ctla-4, and FOXP3 in colorectal cancer draining lymph nodes.
    Yuan L; Tan Z; Huang J; Chen F; Hambly BD; Bao S; Tao K
    Front Immunol; 2024; 15():1384548. PubMed ID: 38533512
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical factors associated with severity in patients with inflammatory bowel disease in Brazil based on 2-year national registry data from GEDIIB.
    Fróes RSB; Andrade AR; Faria MAG; de Souza HSP; Parra RS; Zaltman C; Dos Santos CHM; Bafutto M; Quaresma AB; Santana GO; Luporini RL; de Lima Junior SF; Miszputen SJ; de Souza MM; Herrerias GSP; Junior RLK; do Nascimento CR; Féres O; de Barros JR; Sassaki LY; Saad-Hossne R
    Sci Rep; 2024 Feb; 14(1):4314. PubMed ID: 38383742
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Inflammatory bowel diseases: Transformation of representations. A review].
    Maev IV; Bakulin IG; Skalinskaya MI; Skazyvaeva EV
    Ter Arkh; 2023 Dec; 95(12):1064-1074. PubMed ID: 38158940
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prolonged preoperative sedentary time is a risk factor for postoperative ileus in patients with colorectal cancer: a propensity score-matched retrospective study.
    Yanagisawa T; Tatematsu N; Horiuchi M; Migitaka S; Yasuda S; Itatsu K; Kubota T; Sugiura H
    Support Care Cancer; 2023 Dec; 32(1):54. PubMed ID: 38129532
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Post-colonoscopy rectal cancer in Swedish patients with Crohn's disease 2001-2015: a population-based case review study.
    Stjärngrim J; Ekbom A; Widman L; Hultcrantz R; Forsberg A
    Eur J Gastroenterol Hepatol; 2023 Dec; 35(12):1334-1340. PubMed ID: 37942755
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Elevated Liver Fibrosis Progression in Isolated PSC Patients and Increased Malignancy Risk in a PSC-IBD Cohort: A Retrospective Study.
    Rennebaum F; Demmig C; Schmidt HH; Vollenberg R; Tepasse PR; Trebicka J; Gu W; Ullerich H; Kabar I; Cordes F
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895106
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Polygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel disease.
    Wang MH; Friton JJ; Raffals LE; Leighton JA; Pasha SF; Picco MF; Monroe K; Nix BD; Newberry RD; Faubion WA
    BMJ Open Gastroenterol; 2023 Oct; 10(1):. PubMed ID: 37832963
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification of a seven autophagy-related gene pairs signature for the diagnosis of colorectal cancer using the RankComp algorithm.
    Song QS; Wu HJ; Lin Q; Tang YK
    J Bioinform Comput Biol; 2023 Jun; 21(3):2350012. PubMed ID: 37325865
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Assessment of essential and toxic elemental concentrations in tumor and non-tumor tissues with risk of colorectal carcinoma in Pakistan.
    Qayyum MA; Farooq T; Baig A; Bokhari TH; Anjum MN; Mahmood MH; Ashraf AR; Muddassir K; Ahmad M
    J Trace Elem Med Biol; 2023 Sep; 79():127234. PubMed ID: 37302218
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Characteristics, Clinical Outcomes, and Prognosis of Anal and Pouch-related Carcinoma in Patients With Crohn's Disease.
    Suttichaimongkol T; Loftus EV
    Inflamm Bowel Dis; 2024 Apr; 30(4):547-553. PubMed ID: 37279944
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic significances of PD-L1- and ctla-4-positive T cells and positive correlations of immunosuppressive marker expression between cancer tissue and peripheral blood in patients with gastric cancer.
    Lee KH; Kim SJ; Woo JS; Lee SY; Jhun J; Moon J; Jung YJ; Cho ML; Song KY
    Front Immunol; 2023; 14():1138743. PubMed ID: 37153541
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Risk of anorectal cancer in patients with Crohn's disease and perianal fistula: a nationwide Danish cohort study.
    El-Hussuna A; Lemser CE; Iversen AT; Allin KH; Jess T
    Colorectal Dis; 2023 Jul; 25(7):1453-1459. PubMed ID: 37086006
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Single-Cell Sequencing-Based Validation of T Cell-Associated Diagnostic Model Genes and Drug Response in Crohn's Disease.
    Dai Z; Zhang J; Xu W; Du P; Wang Z; Liu Y
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047025
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Inflammatory Bowel Disease and Risk of colorectal Polyps: A Nationwide Population-Based Cohort Study From Sweden.
    Axelrad JE; Olén O; Söderling J; Roelstraete B; Khalili H; Song M; Faye A; Eberhardson M; Halfvarson J; Ludvigsson JF
    J Crohns Colitis; 2023 Oct; 17(9):1395-1409. PubMed ID: 36994851
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Subclinical bowel inflammation increases healthcare resources utilization and steroid use before diagnosis of inflammatory bowel disease.
    Rodríguez-Lago I; Aguirre U; Ramírez de la Piscina P; Muñagorri A; Zapata E; Higuera R; Montalvo I; Iriarte A; Fernández-Calderón M; Arreba P; Carrascosa J; Cabriada JL; Barreiro-de Acosta M
    United European Gastroenterol J; 2023 Feb; 11(1):9-18. PubMed ID: 36547009
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Protective Role of
    Aleksandrova E; Vlaykova T; Ananiev J; Gulubova M
    Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36422171
    [No Abstract]    [Full Text] [Related]  

  • 18. Old and New Blood Markers in Human colorectal cancer.
    Wautier JL; Wautier MP
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361758
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Post-inflammatory Polyp Burden as a Prognostic Marker of Disease-outcome in Patients with Inflammatory Bowel Disease.
    Ellul P; Schembri J; Vella Baldacchino A; Molnár T; Resal T; Allocca M; Furfaro F; Dal Buono A; Theodoropoulou A; Fragaki M; Tsoukali E; Mantzaris GJ; Phillips FM; Radford S; Moran G; Gonzalez H; Sebastian S; Fousekis F; Christodoulou D; Snir I; Lerner Z; Yanai H; Michalopoulos G; Tua J; Camilleri L; Papamichael K; Karmiris K; Katsanos K
    J Crohns Colitis; 2023 Apr; 17(4):489-496. PubMed ID: 36322687
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Increased Risk of cancer and Mortality in a Large French Population-Based Paediatric-Onset Inflammatory Bowel Disease Retrospective Cohort.
    Dupont-Lucas C; Leroyer A; Ley D; Spyckerelle C; Bertrand V; Turck D; Savoye G; Maunoury V; Guillon N; Fumery M; Sarter H; Gower-Rousseau C;
    J Crohns Colitis; 2023 Apr; 17(4):524-534. PubMed ID: 36316987
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.